News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

LAB21 Limited Partners With Major Pharmaceutical Company to Develop New Companion Diagnostic Assay


6/26/2012 10:53:24 AM

CAMBRIDGE, England--(BUSINESS WIRE)--Lab21 Limited, the global specialist in personalised medicine and clinical diagnostics, has entered into an agreement with one of the world’s leading pharmaceutical companies to develop, manufacture and distribute a new companion diagnostic assay for the detection of specific mutations in colorectal cancer samples to select patients for the partner’s therapeutic monoclonal antibody.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES